POWER Point of Care Effect on Satisfaction of Treatment
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
To compare the subject satisfaction rating in women treated for postmenopausal osteoporosis
with Actonel 35mg Once-a-Week for 24 weeks, and receiving feedback information, after 12
weeks of treatment, based on bone resorption marker results using the NTx Point-Of-Care (POC)
device, to similar women treated as per regular clinical practice